Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)

The objective was to evaluate the efficacy of Nab-paclitaxel in combination with FOLFOX for RGA patients.

Source: European Journal of Cancer - December 7, 2018 Category: Cancer & Oncology Authors: S. Watson, C. de la Fouchardi ère, S. Kim, R. Cohen, J.B. Bachet, C. Tournigand, J.M. Ferraz, M. Lefevre, D. Colin, M. Svrcek, A. Meurisse, C. Louvet Tags: Original Research Source Type: research